Entering text into the input field will update the search result below

AstraZeneca sends T-cell engagers higher after TeneoTwo acquisition

Jul. 05, 2022 12:47 PM ETAstraZeneca PLC (AZN)MGNX, CTMX, SYRS, HARP, JANXBy: Dulan Lokuwithana, SA News Editor

AstraZeneca plant. AstraZeneca has been working on a vaccine for the Coronavirus, COVID and COVID-19.

jetcityimage/iStock Editorial via Getty Images

Companies focused on a class of drugs known as T-cell engagers are trading higher Tuesday after AstraZeneca (NASDAQ:AZN) announced an agreement to acquire the U.S.-based TeneoTwo for a total consideration of up

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About AZN

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
AstraZeneca PLC
Roche Holding AG
Pfizer Inc.
Merck & Co., Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.